- Home
- / Syra Health
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Syra Health financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.5
2024-10-29
Market Capitalization
$4.8 M
2024-10-29
Revenue
$7.2 M
FY, 2025
CreditSafe Score
?
Score changed on Jul 22, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|
| Revenue | 5.5M | 8.0M | 7.2M |
| Cost of goods sold | 4.1M | 6.3M | 4.7M |
| Gross profit | 1.4M | 1.7M | 2.5M |
| Gross profit margin, % | 20.7% | 34.4% | |
| General and administrative expense | 1.1M | 1.4M | 1.1M |
| Operating expense total | 4.3M | 5.4M | 3.4M |
| Depreciation and amortization | 20.5K | ||
| EBIT | (2.9M) | (3.8M) | (904.3K) |
| EBIT margin, % | -47.2% | -12.5% | |
| Interest income | 2.9K | 21.2K | 21.3K |
| Interest expense | 53.7K | 15.6K | |
| Net Income | (2.9M) | (3.8M) | (896.3K) |
| EPS | (0.5) | (0.1) |